Analysts at StockNews.com began coverage on shares of Global Cord Blood (NYSE:CO - Get Free Report) in a report released on Friday. The firm set a "strong-buy" rating on the medical research company's stock.
Global Cord Blood Trading Down 3.7%
NYSE CO traded down $0.04 on Friday, reaching $1.05. The stock had a trading volume of 3,949 shares, compared to its average volume of 216,519. The business has a 50 day moving average price of $0.95 and a 200 day moving average price of $1.09. Global Cord Blood has a 1 year low of $2.03 and a 1 year high of $5.50. The company has a market capitalization of $127.63 million, a price-to-earnings ratio of 1.64 and a beta of 0.16.
Global Cord Blood Company Profile
(
Get Free Report)
Global Cord Blood operates as a holding company, which engages in the provision of cord blood banking services. It provides cord blood processing and storage service. The company also offers cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services. The firm preserves cord blood units donated by the public and provides matching services on such donated units and deliver matching units to patients in need of transplants.
Read More
Before you consider Global Cord Blood, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Global Cord Blood wasn't on the list.
While Global Cord Blood currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
